Press Releases

 
Press Releases
  Date Title View
Jun 29, 2017
ALBANY, N.Y., June 29, 2017 /PRNewswire/ -- Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the early termination of the waiting period under the Hart-S...
Jun 6, 2017
ALBANY, N.Y., June 6, 2017 /PRNewswire/ -- Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced it has signed a definitive agreement to be acquired by affili...
Jun 2, 2017
ALBANY, N.Y., June 2, 2017 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the Jefferies Healthcare Conference on Tuesday, June 6, 2017 at 3:00 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web...
May 9, 2017
ALBANY, N.Y., May 9, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2017 and provided an update to its outlook for 2017. Highlights: First quarter total revenue of $163.8 million, up 55% from 2016 First quarter basic and diluted EPS $(0.25); non-GAAP...
May 2, 2017
ALBANY, N.Y., May 2, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for drug substance development and manufacturing services. The NCATS award will support the Division of Pre-...
Apr 26, 2017
WEST LAFAYETTE, Ind., April 26, 2017 /PRNewswire/ -- SSCI, a division of Albany Molecular Research Inc. (AMRI), has been recognized by Global Health & Pharma (GHP) magazine as the winner of the 2017 Biotechnology Award for Best Global Research & Manufacturing Company in the United States.  "I am truly honored to accept this award on behalf ...
Apr 25, 2017
ALBANY, N.Y., April 25, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2017 financial results before the opening of the market on Tuesday, May 9, 2017.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call can be...
Mar 22, 2017
ALBANY, N.Y., March 22, 2017 /PRNewswire/ -- AMRI, a global contract research, development and manufacturing organization that has been working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, has been recognized for its excellence as a contract manufacturing organization (CMO). AMRI has b...
Mar 3, 2017
ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 16, 2017 at 10:45 a.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Re...
Feb 21, 2017
ALBANY, N.Y., Feb. 21, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has entered into an agreement with the pharmaceutical group Ferrer  and Accord Healthcare, Inc. ("Accord Healthcare") to jointly develop and manufacture an undisclosed complex parenteral drug product for registration and subsequent commercialization in the Unite...
Page:
1
... NextLast
= add release to Briefcase